Clover Health

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness

Retrieved on: 
Tuesday, March 19, 2024
Learning, Artificiality, Clover Health, Partnership, Risk, Patient, Quartet, Transport, Quality of life, Artificial intelligence, Medicine, CMO, SMI, DSM-IV codes, Social, Palliative care, Physician, Practitioner, Nursing

FRANKLIN, Tenn., March 19, 2024 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or the “Company”) announced a partnership with Quartet Health, a value-based behavioral health care enablement and delivery company, to increase the support and resources provided to Clover members with serious mental illness (SMI) through the Company’s home-based care delivery unit, Clover Home Care.

Key Points: 
  • FRANKLIN, Tenn., March 19, 2024 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or the “Company”) announced a partnership with Quartet Health, a value-based behavioral health care enablement and delivery company, to increase the support and resources provided to Clover members with serious mental illness (SMI) through the Company’s home-based care delivery unit, Clover Home Care.
  • As part of this partnership, Quartet will use its expert care teams to augment Clover Home Care’s capabilities.
  • Quartet’s clinicians will also begin using the Clover Assistant platform to deliver care to the Clover patients under its care.
  • As of January 1, Clover Home Care with Whole Health by Quartet Health is available to eligible members in New Jersey for no additional cost.

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance

Retrieved on: 
Tuesday, March 12, 2024
Insurance, PPO, Clover, Medicare, MCR, Economics, Clover Health

FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

Key Points: 
  • FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a managed care company focused on physician enablement, today reported financial results for the fourth quarter and full year 2023.
  • For the fourth quarter 2023, the Company reported revenue of $510.3 million and net loss of $70.5 million, with full-year revenue of $2,033.7 million and net loss of $213.4 million.
  • Insurance revenue during the fourth quarter grew by 12% to $303.1 million, and grew by 14% to $1,235.8 million for full-year 2023.
  • Insurance MCR also meaningfully improved to 82.4% in the fourth quarter and 81.2% for full-year 2023, as compared to 92.4% in the fourth quarter 2022 and 91.8% for full-year 2022.

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage

Retrieved on: 
Thursday, March 7, 2024
PPO, Humana, Clover Health, Medicare, Clover, Region, Management

FRANKLIN, Tenn., March 07, 2024 (GLOBE NEWSWIRE) -- Today Clover Health ("Clover" or "the Company") announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage (MA) division.

Key Points: 
  • FRANKLIN, Tenn., March 07, 2024 (GLOBE NEWSWIRE) -- Today Clover Health ("Clover" or "the Company") announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage (MA) division.
  • Thornton's expertise in driving financial strategies that bolster quality outcomes, member and provider satisfaction, and sustainable business expansion makes him an ideal fit for Clover.
  • "I am thrilled to join the team at Clover Health and drive forward their PPO-first approach in the Medicare Advantage space," said Thornton.
  • His leadership will be instrumental in advancing our PPO-first approach, ensuring we continue to thrive in Medicare Advantage through our technology-driven, patient-centered care model."

Clover Health Provides Business Update and Full-Year 2024 Objectives

Retrieved on: 
Wednesday, January 10, 2024
Conditional sentence, Clover Health, Health, Medicare, PPO, Physician, Growth, Risk management

FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, announced today that it is targeting Adjusted EBITDA profitability for the full-year 2024.

Key Points: 
  • FRANKLIN, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, announced today that it is targeting Adjusted EBITDA profitability for the full-year 2024.
  • (1)
    “I believe that we are at a critical inflection point in the trajectory of our business.
  • “We are targeting to achieve our goal to deliver profitability on an Adjusted EBITDA basis for full-year 2024.
  • However, this business update, and our strengthened conviction in targeting Adjusted EBITDA profitability this year, highlights the anticipated favorable impact of our ongoing strategy to deliver a sustainable, profitable Clover Health to our stakeholders.”
    Adjusted EBITDA is a non-GAAP financial measure.

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance

Retrieved on: 
Thursday, December 21, 2023
Yale University, Economics, Medicine, MYGN, CFO, Leffler, Emory University, Genetics, Myriad Genetics, Genetic testing, Growth, Clover Health, Risk management, History, Management

Leffler will succeed Myriad CFO Bryan Riggsbee who is retiring.

Key Points: 
  • Leffler will succeed Myriad CFO Bryan Riggsbee who is retiring.
  • Riggsbee will continue as a strategic advisor through March 31, 2024, to ensure a smooth transition.
  • Leffler has held numerous financial leadership positions and brings expertise in finance transformation, acquisitions and integrations, as well as risk management.
  • At its third quarter 2023 earnings call on November 6, Myriad updated its 2023 financial guidance and introduced 2024 revenue guidance.

Clover Health Exits ACO REACH to Accelerate Path to Profitability

Retrieved on: 
Friday, December 1, 2023
Partnership, Physician, UST, Medicare, ACO, Optimism, Clover Health, CMS, Pharmaceutical industry

Written notification will also be sent to all participating physicians in accordance with CMS requirements.

Key Points: 
  • Written notification will also be sent to all participating physicians in accordance with CMS requirements.
  • The decision will have no impact on its ACO REACH beneficiaries, and Clover will continue to fulfill all of its obligations under the ACO REACH Program for the 2023 performance year.
  • We remain focused on our goal to deliver a sustainable, profitable Clover Heath to our members and investors.
  • Overall, this narrower focus gives us even greater optimism that Clover Health can deliver profitability on an Adjusted EBITDA basis for full-year 2024.”

Clover Health and WellBe Senior Medical Partner to Bring In-home Medical Care to Atlanta Patients and Across Rural Georgia

Retrieved on: 
Tuesday, November 7, 2023
Practitioner, Association for the Wellbeing of Children in Healthcare, Health, Physician, Clover Health, MD, TTY, Caregiver, Partnership, Travel, Patient, Social, Completeness, Health insurance, Nursing, Clover

ATLANTA, Nov. 7, 2023 /PRNewswire/ -- Clover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions.

Key Points: 
  • ATLANTA, Nov. 7, 2023 /PRNewswire/ -- Clover Health and WellBe Senior Medical have teamed up to deliver home-based medical care to residents of Georgia living with multiple complex health conditions.
  • WellBe Senior Medical puts patients first by delivering medical visits to members at their home.
  • WellBe Senior Medical is an in-home medical care group specializing in caring for individuals with multiple chronic conditions.
  • Our partnership with WellBe Senior Medical will give members access to personalized medical care in the comfort of their homes."

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance

Retrieved on: 
Monday, November 6, 2023
Optimism, Medicare, EBITDA, Clover Health, Software, Key (company), Growth, PPO, Partnership, Clover, MCR, UST, Insurance

FRANKLIN, Tenn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the third quarter 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

Key Points: 
  • FRANKLIN, Tenn., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the third quarter 2023.
  • For the third quarter 2023, the Company reported revenue of $482.1 million and net loss of $41.5 million.
  • Adjusted EBITDA in the third quarter 2023 significantly improved to a loss of $5.1 million compared to the prior year period loss of $55.5 million.
  • “We are proud to report another quarter of significantly improved Adjusted EBITDA driven by strong Insurance MCR performance,” said Clover Health CEO Andrew Toy.

Clover Health Promotes Karen Soares to General Counsel

Retrieved on: 
Wednesday, November 1, 2023
Dartmouth College, Associate, Toy, Medicare, Clover Health, Organization, Senior, Karen, Soares, Partnership, University, University of Chicago Law School, General counsel, Fried, Frank, Harris, Shriver & Jacobson, Clover

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023.

Key Points: 
  • FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023.
  • “Karen has been a tremendous asset to Clover over the years, providing strategic legal counsel and partnership as our business has continued to evolve.
  • Soares first joined Clover in 2018 as an Associate General Counsel, supporting the contracting, compliance, and product functions.
  • I am honored and excited to step into the role of Clover’s General Counsel as we continue on this important journey,” Soares said.

Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes

Retrieved on: 
Thursday, October 12, 2023
Diagnosis, Health, Data science, A1C, Moyamoya disease, Ophthalmology, Retinopathy, Clover Health, Medicare, Chronic kidney disease, Medicine, Hypoglycemia, Patient, Pharmaceutical industry, Clover, Diabetes

FRANKLIN, Tenn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of diabetes.

Key Points: 
  • FRANKLIN, Tenn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of diabetes.
  • “Early diagnosis and treatment of diabetes in the Medicare population is essential for preventing complications, improving overall health and well being, and reducing the economic burden associated with the condition,” said Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant.
  • “The diabetes comorbidities that CA lists are also important to address.
  • For example, I appreciate seeing evidence of peripheral arterial disease, because that reminds me to get the patient in for additional screening tests.